98%
921
2 minutes
20
Recent advancements in digital-light-processing (DLP)-based bioprinting and hydrogel engineering have enabled novel developments in organs-on-chips. In this work, we designed and developed a multi-material, DLP-based bioprinter for rapid, one-step prototyping of hydrogel-based microfluidic chips. A composite hydrogel bioink based on poly-ethylene-glycol-diacrylate (PEGDA) and gelatin methacryloyl (GelMA) was optimized through varying the bioprinting parameters such as light exposure time, bioink composition, and layer thickness. We showed a wide range of mechanical properties of the microfluidic chips for various ratios of PEGDA:GelMA. Microfluidic features of hydrogel-based chips were then tested using dynamic flow experiments. Human-derived tumor cells were encapsulated in 3D bioprinted structures to demonstrate their bioactivity and cell-friendly environment. Cell seeding experiments then validated the efficacy of the selected bioinks for vascularized micro-tissues. Our biofabrication approach offers a useful tool for the rapid integration of micro-tissue models into organs-on-chips and high-throughput drug screening platforms.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10700126 | PMC |
http://dx.doi.org/10.1088/1758-5090/ac2d78 | DOI Listing |
Micromachines (Basel)
July 2025
School of Mechanical Engineering, Beijing Institute of Technology, Beijing 100081, China.
Glass enjoys a wide range of applications thanks to its superior optical properties and chemical stability. Conventional glass bonding techniques suffer from low efficiency, limited precision, and high cost. Moreover, for multilayer glass bonding, repeated alignment is often required, further complicating the process.
View Article and Find Full Text PDFSensors (Basel)
August 2025
Departments of Biomedical Engineering and Dermatology, University of Rochester, Rochester, NY 14627, USA.
Tissue chips (TCs), otherwise known as organs-on-a-chip (OoC), organ chips (OCs), or microphysiological systems (MPS), are rapidly gaining prominence as an extension of or even replacement for traditional animal models of disease physiology. They also have recognized utility in the context of drug development: for example, data from TCs can now be submitted in place of some animal testing to the FDA. In principle, TCs are structured to allow measurement of any number of outputs that yield information about the tissue.
View Article and Find Full Text PDFSensors (Basel)
August 2025
Department of Biosystems Engineering, Seoul National University, Seoul 08826, Republic of Korea.
Astringency, a complex oral sensation resulting from interactions between mucin and polyphenols, remains difficult to quantify in portable field settings. Therefore, quantifying the aggregation through interactions can enable the classification of the astringency intensity, and assessing the capillary action driven by the surface tension offers an effective approach for this purpose. This study successfully replicates tannic acid (TA)-mucin aggregation on a paper-based microfluidic chip and utilizes machine learning (ML) to analyze the resulting capillary flow dynamics.
View Article and Find Full Text PDFElectrophoresis
August 2025
Laboratory of Medicine, Dalian Medical University, Dalian.
Tumor-macrophage interactions play a key role in various physiological and pathological processes, such as angiogenesis, immune suppression, and extracellular matrix remodeling. In this study, a biomimetic microfluidic chip was developed to simulate the immune microenvironment of glioma through the co-culture of glioma cells and macrophages in a three-dimensional (3D) matrix. Glioma cells were embedded in collagen I solution after forming spheroids in the microwell array chip and subsequently co-cultured with macrophages in different channels.
View Article and Find Full Text PDFBiosensors (Basel)
August 2025
College of Information Science and Engineering, Ritsumeikan University, Osaka 567-8570, Japan.
In recent years, digital microfluidic biochips (DMFBs), based on microfluidic technology, have attracted attention as compact and flexible experimental devices. DMFBs are widely applied in biochemistry and medical fields, including point-of-care clinical diagnostics and PCR testing. Among them, micro electrode dot array (MEDA) biochips, composed of numerous microelectrodes, have overcome the limitations of conventional chips by enabling finer droplet manipulation and real-time sensing, thus significantly improving experimental efficiency.
View Article and Find Full Text PDF